Biotechnology

Pro Te Solutio - Vol. 6 No. 1 February 2013

by Hemant Gupta, Keishunna Randall, Travis Swearingen | Butler, Snow, O'Mara, Stevens and Cannada,... on 5/22/2013

In This Issue: - Can Experts Testify as to the Ethics or State of Mind of Corporate Defendants? - Patent Reform for Biotech Companies - United States v. Caronia and its Implications for Off-Label...more

Bowman v. Monsanto: Self-Replicating Biotech and Software Left at the Alter?

by Robert Isackson | Orrick, Herrington & Sutcliffe LLP on 5/15/2013

Today, in a case having the potential to upset the agricultural biotech industry, Justice Elena Kagan delivered the U.S. Supreme Court’s unanimous decision rejecting farmer Vernon Hugh Bowman’s patent exhaustion defense....more

The Myriad Case and "Gene" Patents: Much Ado about Nothing?

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 5/15/2013

The biggest concern of the biotechnology industry caused by the impending Supreme Court decision in the AMP v. Myriad Genetics case is the threat to existing patents having claims to isolated human DNA (and the DNA from other...more

Legal Alert: Monsanto Ruling Protects Innovators of Self-Replicating Biotechnology

by William Warren, David Wigley, Ph.D. | Sutherland Asbill & Brennan LLP on 5/15/2013

On May 13, 2013, a unanimous U.S. Supreme Court held in Monsan to v. Bowman that the doctrine of patent exhaustion does not permit a farmer to reproduce patented seeds for planting and harvesting without the patent holder's...more

Rubin v. General Hospital Corp. (Fed. Cir. 2013)

by Donald Zuhn | McDonnell Boehnen Hulbert & Berghoff LLP on 5/8/2013

On March 28, the Federal Circuit in Rubin v. General Hospital Corp. affirmed judgment by the District Court for the District of Massachusetts dismissing the suit brought by Drs. Berish Rubin and Sylvia Anderson against The...more

Biotech Venture Funding Down 33% in First Quarter

by Donald Zuhn | McDonnell Boehnen Hulbert & Berghoff LLP on 5/1/2013

Earlier this month, the National Venture Capital Association (NVCA), a trade association representing the U.S. venture capital industry, released the results of its MoneyTree Report on venture funding for the first quarter of...more

[Legal Perspective] Can Human Genes Be Patented?

by JD Supra Law News on 4/24/2013

Earlier this month, the United States Supreme Court heard oral arguments in a case that comes down to a single question: can human genes be patented?...more

Court Report -- April 22, 2013

by Sherri Oslick | McDonnell Boehnen Hulbert & Berghoff LLP on 4/22/2013

About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. - Depomed, Inc. v. Endo Pharmaceuticals Inc. 3:13-cv-02467; filed April 17, 2013 in the District Court of New Jersey:...more

Can You Patent Human Genes? ACLU Says No [Video]

by Bloomberg Law on 4/12/2013

April 12 (Bloomberg Law) -- On April 15, 2013, the United States Supreme Court will hear oral arguments for Association for Molecular Pathology v. Myriad Genetics, Inc. The case centers on whether patents may be granted on...more

Going on the Offense: Proactive Strategies to Reduce Uncertainty [Video]

by LEVICK on 4/2/2013

In this LEVICK Daily video interview, we discuss an upcoming panel discussion at the 2013 BIO International Convention entitled, Going on the Offense: Proactive Strategies to Reduce Uncertainty. During the discussion, which...more

News from Abroad: UK Court of Appeal Upholds Invalidity of Enantiomer Patent

by McDonnell Boehnen Hulbert & Berghoff LLP on 4/1/2013

Originally published in WP Thompson & Co. on April 1, 2013. The "Obvious to Try" Test Is Overused in Assessing Obviousness - The UK Court of Appeal Decision in Novartis AG vs Generics (UK) Ltd (trading as United...more

Briefing the Supreme Court in Myriad

by Courtenay C. Brinckerhoff | Foley & Lardner LLP on 3/29/2013

March 15, 2013 was a big deadline for patent applicants seeking to secure first-to-invent filing dates for U.S. patent applications, but April 15 will be a big day for the biotechnology industry, when the Supreme Court hears...more

Supreme Court To Hear Oral Arguments in Landmark Patent Case

by Baker, Donelson, Bearman, Caldwell &... on 3/28/2013

April 15 is a big day for biotechnology, pharmaceutical, and medical diagnostic companies at the Supreme Court, as justices begin a new session by hearing oral arguments in a landmark case involving the patentability of...more

Sharing an Umbrella

by MoFo Tech on 3/26/2013

Big Pharma and academia cement big deals in the quest for bigger prizes - With the patents of many highly profitable blockbuster drugs expiring over the course of a few years, the search is on for new drugs to fill...more

GEN Compiles List of Top Biopharma R&D Spenders

by Donald Zuhn | McDonnell Boehnen Hulbert & Berghoff LLP on 3/21/2013

Earlier this month, Genetic Engineering & Biotechnology News published its list of the top 20 best-selling prescription drugs worldwide for 2012 (see "GEN Compiles List of Top Selling Drugs for 2012"). The biotech...more

Episode 91 – Michael Funk Discusses Labeling Foods Containing GMOs March 14, 2013

by Wendel, Rosen, Black & Dean LLP on 3/15/2013

In Episode 91 of The Wendel Forum (originally aired on March 9, 2013, on 960 KNEW AM radio), show moderator Dick Lyons, co-founder of Wendel Rosen’s sustainable business practice group, welcomes Michael Funk. Funk is a...more

MoFo BioMeter - Volume 2, Issue 1: February 2013

by Anelia V. Delcheva, Stephen B. Thau | Morrison & Foerster LLP on 2/25/2013

Phase 2 Deals Dominate Q4 and Full Year 2012 - Morrison & Foerster is pleased to release the MoFo BioMeter for the fourth quarter of 2012 and for the full year of 2012. The fourth quarter of 2012 saw an uptick in...more

MBHB Snippets: Review of Developments in Intellectual Property Law - Winter 2013 - Volume 11, Issue 1: Federal Courts Debate Safe...

by Patrick Gattari, Nicole Grimm | McDonnell Boehnen Hulbert & Berghoff LLP on 2/19/2013

Patent protection is a critical driver of value for the biotech industry. One of the unique aspects of biotech patents, however, is that many otherwise infringing activities are exempt from claims of patent infringement when...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

Pro Te Solutio - Vol. 6 No. 1 February 2013

Bowman v. Monsanto: Self-Replicating Biotech and Software Left at the Alter?

The Myriad Case and "Gene" Patents: Much Ado about Nothing?

Legal Alert: Monsanto Ruling Protects Innovators of Self-Replicating Biotechnology

Rubin v. General Hospital Corp. (Fed. Cir. 2013)

Biotech Venture Funding Down 33% in First Quarter

[Legal Perspective] Can Human Genes Be Patented?

Court Report -- April 22, 2013

Can You Patent Human Genes? ACLU Says No [Video]

Going on the Offense: Proactive Strategies to Reduce Uncertainty [Video]

News from Abroad: UK Court of Appeal Upholds Invalidity of Enantiomer Patent

Briefing the Supreme Court in Myriad

Supreme Court To Hear Oral Arguments in Landmark Patent Case

Sharing an Umbrella

GEN Compiles List of Top Biopharma R&D Spenders

Episode 91 – Michael Funk Discusses Labeling Foods Containing GMOs March 14, 2013

MoFo BioMeter - Volume 2, Issue 1: February 2013

MBHB Snippets: Review of Developments in Intellectual Property Law - Winter 2013 - Volume 11, Issue 1: Federal Courts Debate Safe...

MBHB Snippets: Review of Developments in Intellectual Property Law - Winter 2013 - Volume 11, Issue 1

Court Report -- February 16, 2013

News from Abroad: Federal Court of Australia Affirms Patentability of Isolated Nucleic Acids

Annual Venture Funding Drops for First Time in Three Years

It Ain't Necessarily So Down on the Farm: Not All Farmers Agree with Farmer Bowman in Bowman v. Monsanto

BayhDol25 Files Amicus Brief in Bowman v. Monsanto

IPO Files Amicus Brief in Support of Respondents in Bowman v. Monsanto

Can You Patent Human Genes? ACLU Says No [Video]

Going on the Offense: Proactive Strategies to Reduce Uncertainty [Video]

Expand Your Reach